Impact of an electronically-integrated clinical pathway on hospital initiation of medications for alcohol use disorder and subsequent hospital utilization.
Kelsey O Cole, Melissa B Weimer, Kaicheng Wang, David A Fiellin, Anisha J Advani, Nidhi Shah, Christopher T Zemaitis, Deborah J Rhodes
{"title":"Impact of an electronically-integrated clinical pathway on hospital initiation of medications for alcohol use disorder and subsequent hospital utilization.","authors":"Kelsey O Cole, Melissa B Weimer, Kaicheng Wang, David A Fiellin, Anisha J Advani, Nidhi Shah, Christopher T Zemaitis, Deborah J Rhodes","doi":"10.1002/jhm.70049","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Medications for alcohol use disorder (MAUD) are underutilized and multiple barriers and disparities in treatment initiation have been identified. Effective hospital-based strategies to promote MAUD use are not well-defined.</p><p><strong>Objective: </strong>To determine whether an electronic health record (EHR)-integrated clinical pathway increases MAUD initiation.</p><p><strong>Methods: </strong>We conducted a prospective observational cohort study with consecutive adult inpatients diagnosed with alcohol use disorder (AUD) and withdrawal requiring treatment who were admitted to a health system comprising a mix of community and tertiary academic medical centers. The impact of voluntary use of an AUD EHR-integrated clinical pathway on MAUD initiation (main outcome) and ED return or readmission for any cause within 30 days of discharge (secondary outcomes) was evaluated.</p><p><strong>Results: </strong>Among 2630 inpatient medicine encounters, the pathway was utilized in 17.8%. Pathway utilization was associated with 4.31 (confidence interval [CI]: 3.10-5.99, p < .001) increased odds of MAUD initiation as compared with encounters without pathway utilization (31% vs. 15.4%). There were no differences in rates of 30-day ED returns (odds ratio [OR]: 0.76; 95% confidence interval [CI]: 0.35-1.62; p = .47) or 30-day readmissions (OR: 1.19; 95% CI: 0.80-1.76; p = .40) and no differences in MAUD initiation by race or ethnicity when the pathway was utilized versus not utilized.</p><p><strong>Conclusions and relevance: </strong>Utilization of an EHR-integrated clinical pathway for individuals with AUD significantly increased MAUD initiation at hospital discharge. These findings support the use of an EHR-integrated clinical pathway as an implementation tool for overcoming barriers to MAUD initiation and may be a generalizable strategy for increasing low rates of MAUD prescribing for patients with AUD.</p>","PeriodicalId":94084,"journal":{"name":"Journal of hospital medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of hospital medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/jhm.70049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Medications for alcohol use disorder (MAUD) are underutilized and multiple barriers and disparities in treatment initiation have been identified. Effective hospital-based strategies to promote MAUD use are not well-defined.
Objective: To determine whether an electronic health record (EHR)-integrated clinical pathway increases MAUD initiation.
Methods: We conducted a prospective observational cohort study with consecutive adult inpatients diagnosed with alcohol use disorder (AUD) and withdrawal requiring treatment who were admitted to a health system comprising a mix of community and tertiary academic medical centers. The impact of voluntary use of an AUD EHR-integrated clinical pathway on MAUD initiation (main outcome) and ED return or readmission for any cause within 30 days of discharge (secondary outcomes) was evaluated.
Results: Among 2630 inpatient medicine encounters, the pathway was utilized in 17.8%. Pathway utilization was associated with 4.31 (confidence interval [CI]: 3.10-5.99, p < .001) increased odds of MAUD initiation as compared with encounters without pathway utilization (31% vs. 15.4%). There were no differences in rates of 30-day ED returns (odds ratio [OR]: 0.76; 95% confidence interval [CI]: 0.35-1.62; p = .47) or 30-day readmissions (OR: 1.19; 95% CI: 0.80-1.76; p = .40) and no differences in MAUD initiation by race or ethnicity when the pathway was utilized versus not utilized.
Conclusions and relevance: Utilization of an EHR-integrated clinical pathway for individuals with AUD significantly increased MAUD initiation at hospital discharge. These findings support the use of an EHR-integrated clinical pathway as an implementation tool for overcoming barriers to MAUD initiation and may be a generalizable strategy for increasing low rates of MAUD prescribing for patients with AUD.